A Comparative Histopathological Study of Heparin Coated and Uncoated Polytetrafluoroethylene Shunts in Children With Congenital Heart Defect

Objective: Recently, heparin coated polytetrafluoroethylene (PTFE) shunts are available and are believed to improve inherent shunt problems such as thrombosis and excessive and incomplete neointima formation or occlusion. We aimed at comparing the potential histopathological differences in the neointima (in) between uncoated (UCS) PTFE shunts and heparin coated (HCS) PTFE shunts. Materials and Methods: Thirteen shunts (six UCS and seven HCS) were analyzed. The specimens were fixed in formalin, embedded in paraffin or in methylmethacrylate, and characterized by standard and immunohistochemical staining. The thickness of pseudointima proliferation was graded as follows: 0 = no cell layers, 1 = few layers <100 µm, 2 = partial layers >100 µm, 3 = complete layers <300 µm, 4 = complete layers >300 µm, and 5 = occlusion. Results: Mean shunt size was 3.4 ± 0.2 mm in UCS and 3.1 ± 0.2 mm in HCS (P = .053). Mean time of implantation was 163 ± 75 days in UCS and 97 ± 52 days in HCS (P = .091). There were no significant differences in the proportion of patients with functionally single ventricle, body surface area, age at implantation, or implantation type, between both groups. Shunt occlusion did not occur. Unplanned shunt explantation due to cyanosis was performed in one patient in each group. Partial thrombus formation was observed in one UCS (P = .462). There was complete endothelialization in 50% of UCS and 86% of HCS (P = .266). The grade of pseudointima proliferation was 1.8 ± 0.4 in UCS and 1.7 ± 0.5 in HCS (P = .646). Conclusions: The histopathological workup of PTFE shunts revealed equally partial endothelialization and discrete pseudointima proliferation in both the groups. The process of endothelialization may be faster in HCS.

[1]  C. Male,et al.  Anticoagulation in Children Undergoing Cardiac Surgery , 2011, Seminars in thrombosis and hemostasis.

[2]  Martin Glöckler,et al.  Early obstruction of decellularized xenogenic valves in pediatric patients: involvement of inflammatory and fibroproliferative processes. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[3]  E. Mattsson,et al.  Improved patency and reduced intimal hyperplasia in PTFE grafts with luminal immobilized heparin compared with standard PTFE grafts at six months in a sheep model. , 2010, The Journal of cardiovascular surgery.

[4]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[5]  Bradford J. Kim,et al.  Two thousand Blalock-Taussig shunts: a six-decade experience. , 2007, The Annals of thoracic surgery.

[6]  N. B. Lerner,et al.  Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. , 2007, The Annals of thoracic surgery.

[7]  R. Califf,et al.  Clinical Outcomes of Palliative Surgery Including a Systemic-to-Pulmonary Artery Shunt in Infants With Cyanotic Congenital Heart Disease: Does Aspirin Make a Difference? , 2007, Circulation.

[8]  R. Lange,et al.  Early graft failure of small-sized porcine valved conduits in reconstruction of the right ventricular outflow tract. , 2006, The Annals of thoracic surgery.

[9]  Dr. M. Sigler,et al.  Biocompatibility screening in cardiovascular implants , 2005, Zeitschrift für Kardiologie.

[10]  A. Lumsden,et al.  Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. , 2004, Journal of vascular surgery.

[11]  H. Sievert,et al.  Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. , 2004, Journal of the American College of Cardiology.

[12]  F. Pigula,et al.  Interim mortality in infants with systemic-to-pulmonary artery shunts. , 2003, The Annals of thoracic surgery.

[13]  S. Rafii,et al.  Contribution of marrow-derived progenitors to vascular and cardiac regeneration. , 2002, Seminars in cell & developmental biology.

[14]  J. Monro,et al.  Twelve year experience with the modified Blalock-Taussig shunt in neonates. , 1992, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  K. Watterson,et al.  Very small pulmonary arteries: central end-to-side shunt. , 1991, The Annals of thoracic surgery.

[16]  S. Moncada,et al.  The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.

[17]  D. Gibbons,et al.  Effect of implant surface chemistry upon arterial thrombosis. , 1979, Journal of biomedical materials research.

[18]  H. Taussig,et al.  The Surgical Treatment of Malformations of the Heart: In Which There Is Pulmonary Stenosis or Pulmonary Atresia , 1945 .